Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment


Washington, D.C., (December 4, 2018)
—MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD.  Read more.

Recent Posts

Contact

Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]